Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

AbstractBackgroundAntimicrobial resistance (AMR) is a major global public health concern and its surveillance is a fundamental tool for monitoring the development of AMR. In 1998, the Nepalese Ministry of Health (MOH) launched an Infectious Disease (ID) programme. The key components of the programme were to establish a surveillance programme for AMR and to develop awareness among physicians regarding AMR and rational drug usage in Nepal.MethodsAn AMR surveillance programme was established and implemented by the Nepalese MOH in partnership with the International Centre for Diarrhoeal Disease Research, Bangladesh (ICDDR, B) from 1998 to 2003. From 2004 to 2012, the programme was integrated and maintained as a core activity of the National Public Health Laboratory (NPHL) and resulted in an increased number of participating laboratories and pathogens brought under surveillance. The main strategies were to build national capacity on isolation, identification and AMR testing of bacterial pathogens, establish laboratory networking and an External Quality Assessment (EQA) programme, promote standardised recording and reporting of results, and to ensure timely analysis and dissemination of data for advocacy and national policy adaptations. The programme was initiated by nine participating laboratories performing AMR surveillance onVibrio cholerae, Shigellaspp.,Streptococcus pneumoniae,Haemophilus influenzae,andNeisseria gonorrhoeae.ResultsThe number of participating laboratories was ultimately increased to 13 and the number of pathogens under surveillance was increased to seven (Salmonellaspp. was added to the surveillance programme in 2002 and extended spectrum β-lactamase producingEscherichia coliin 2011). From 1999 to 2012, data were available on 17,103 bacterial isolates. During the AMR programme, we observed changing trends in serovars/ species forSalmonellaspp., Shigellaspp.and V. choleraeand changing AMR trend for all organisms. Notably,N. gonorrhoeaeisolates demonstrated increasing resistance to ciprofloxacin. Additionally, the performance of the participating laboratories improved as shown by annual EQA data evaluation.ConclusionsThis Nepalese AMR programme continues and serves as a model for sustainable surveillance of AMR monitoring in resource limited settings.

More information Original publication

DOI

10.1186/1471-2458-14-269

Type

Journal article

Publisher

Springer Science and Business Media LLC

Publication Date

2014-12-01T00:00:00+00:00

Volume

14